Despite posting strong results in the final quarter of 2025, MSD (Merck & Co) has cut its 2026 guidance more than analysts ...

Priority Review was granted by FDA for the first line metastatic TNBC treatment. Datroway significantly improved survival ...

SanegeneBio has entered into a $1.5bn global licensing agreement with Genentech, part of the Roche Group, for one of its RNAi ...

Nine recommendations for extending therapeutic indications reflect ongoing lifecycle management and utility expansion of ...

Dave Carey, CEO, Preceptis Medical and Michael Manavukas, CEO, co-founder, AcuityMD note the importance of shifting ear tube procedures into the office, reducing anesthesia risk, and how AI-driven ...

PE: What was your experience debuting Trialynx at JP Morgan Healthcare 2026? Schwab: It’s fantastic. This was the culmination ...

Novartis has transformed from a diversified conglomerate into a focused innovative medicines company, with India playing a ...

When Morgan and Karadec attend the murder of a man determined to live forever, they need to find out who his enemies were.

While riding high on the popularity of its weight loss drug Zepbound, the company is quietly building a presence in a cutting ...

SHARJAH, 3rd February, 2026 (WAM) -- The Sharjah Chamber of Commerce and Industry (SCCI) received a trade delegation from the Socialist Republic of Vietnam to discuss ways to strengthen economic and ...

Life sciences innovator and leader in precision-engineered synthetic cell mimic technology expands its UK/EU operations to accelerate cell and gene therapy and pharmaceutical developmentEMERYVILLE ...

The world is in the middle of a peptide drug revolution. These short chains of amino acids—the building blocks of ...